NPT-189

N/A

Report date: 2024/02/18 20:00:30

Base Information

Drug NameNPT-189
Drug Alias NameNPT-189
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionSynuclein alpha inhibitorsMicrotubule-associated protein tau inhibitorsTransthyretin inhibitors +[4] 
TargetsSynuclein alphaMicrotubule-associated protein tauTransthyretin +[4] 
Therapy Area/IndicationsAmyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesProclara Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProclara Biosciences Inc
Active IndicationsN/A
Inactive IndicationsAmyloidosis

Other Information

ATC CodeN/A
Related LinksN/A